OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NFR2/ABC transporter axis in drug resistance of breast cancer cells
Zinat Sargazi, Yalda Yazdani, Amir Tahavvori, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 6, pp. 5407-5414
Closed Access | Times Cited: 17
Zinat Sargazi, Yalda Yazdani, Amir Tahavvori, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 6, pp. 5407-5414
Closed Access | Times Cited: 17
Showing 17 citing articles:
The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target
Samar Sami Alkafaas, Mohamed I. Elsalahaty, Doha F. Ismail, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 26
Samar Sami Alkafaas, Mohamed I. Elsalahaty, Doha F. Ismail, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 26
Investigation of circulating miR-182-3p, miR -382-3p and miR -93, miR -142-3p involved in tamoxifen resistance and sensitivity in luminal-subtype breast cancer patients: a case–control study
Elmira Aboutalebi Vand Beilankouhi, Zohreh Sanaat, Mohammad Ali Hosseinpour Feizi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 2
Elmira Aboutalebi Vand Beilankouhi, Zohreh Sanaat, Mohammad Ali Hosseinpour Feizi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 2
The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer
Hadi Fakheri, Mir Amirhossein Sajadi, Ahmad Afrashteh, et al.
Biochemia Medica (2023) Vol. 33, Iss. 3, pp. 266-278
Open Access | Times Cited: 23
Hadi Fakheri, Mir Amirhossein Sajadi, Ahmad Afrashteh, et al.
Biochemia Medica (2023) Vol. 33, Iss. 3, pp. 266-278
Open Access | Times Cited: 23
Correlation of PTEN signaling pathway and miRNA in breast cancer
Mahya Mohammadi, Ahmad Fazilat, Alireza Soleimani Mamalo, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 15
Mahya Mohammadi, Ahmad Fazilat, Alireza Soleimani Mamalo, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 15
A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer
Leila Kalantari, Zahra Rostami Ghotbabadi, Arsalan Gholipour, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Leila Kalantari, Zahra Rostami Ghotbabadi, Arsalan Gholipour, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Potential roles of the exosome/microRNA axis in breast cancer
Alireza Soleimani Mamalo, Vahid Alivirdiloo, Azadeh Sadeghnejad, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154845-154845
Closed Access | Times Cited: 12
Alireza Soleimani Mamalo, Vahid Alivirdiloo, Azadeh Sadeghnejad, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154845-154845
Closed Access | Times Cited: 12
Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review
Azadeh Fakhrioliaei, Sepideh Tanhaei, Seyed Abbas Pakmehr, et al.
The Journal of Membrane Biology (2024) Vol. 257, Iss. 1-2, pp. 3-16
Closed Access | Times Cited: 4
Azadeh Fakhrioliaei, Sepideh Tanhaei, Seyed Abbas Pakmehr, et al.
The Journal of Membrane Biology (2024) Vol. 257, Iss. 1-2, pp. 3-16
Closed Access | Times Cited: 4
Crosstalk between miRNAs and signaling pathways in the development of drug resistance in breast cancer
Reza Amiri, Poorya Najjari Nabi, Ahmad Fazilat, et al.
Hormone Molecular Biology and Clinical Investigation (2024)
Closed Access | Times Cited: 4
Reza Amiri, Poorya Najjari Nabi, Ahmad Fazilat, et al.
Hormone Molecular Biology and Clinical Investigation (2024)
Closed Access | Times Cited: 4
Edaravone is a Therapeutic Candidate for Doxorubicin‐Induced Cardiomyopathy by Activating the Nrf2 Pathway
Naoki Yoshikawa, Naoto Hirata, Yuichiro Kurone, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access
Naoki Yoshikawa, Naoto Hirata, Yuichiro Kurone, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access
Photobiomodulation mitigates doxorubicin resistance in MDA-MB-231 breast cancer cells: a promising avenue for overcoming chemoresistance
Fatemeh Javani Jouni, Nima Rastegar‐Pouyani, Ahmad Moshaii, et al.
Lasers in Medical Science (2025) Vol. 40, Iss. 1
Closed Access
Fatemeh Javani Jouni, Nima Rastegar‐Pouyani, Ahmad Moshaii, et al.
Lasers in Medical Science (2025) Vol. 40, Iss. 1
Closed Access
The cross-talk between NRF2 and apoptosis in cancer
Elmira Aboutalebi Vand Beilankouhi, Bahman Yousefi, Nasim Hadian, et al.
Medical Molecular Morphology (2025)
Closed Access
Elmira Aboutalebi Vand Beilankouhi, Bahman Yousefi, Nasim Hadian, et al.
Medical Molecular Morphology (2025)
Closed Access
Determining expression changes of ANO7 and SLC38A4 membrane transporters in colorectal cancer
Elaheh Mohandesi Khosroshahi, Mazaher Maghsoudloo, Hossein Fahimi, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34464-e34464
Open Access | Times Cited: 2
Elaheh Mohandesi Khosroshahi, Mazaher Maghsoudloo, Hossein Fahimi, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34464-e34464
Open Access | Times Cited: 2
Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies
Patrízia Limonta, Raffaella Chiaramonte, Lavinia Casati
Cancers (2024) Vol. 16, Iss. 16, pp. 2861-2861
Open Access | Times Cited: 2
Patrízia Limonta, Raffaella Chiaramonte, Lavinia Casati
Cancers (2024) Vol. 16, Iss. 16, pp. 2861-2861
Open Access | Times Cited: 2
Diosgenin inhibited podocyte pyroptosis in diabetic kidney disease by regulating the Nrf2/NLRP3 pathway
Yu Tang, WENXIAO HU, YAJUN PENG, et al.
Biocell (2024) Vol. 48, Iss. 10, pp. 1503-1516
Open Access | Times Cited: 1
Yu Tang, WENXIAO HU, YAJUN PENG, et al.
Biocell (2024) Vol. 48, Iss. 10, pp. 1503-1516
Open Access | Times Cited: 1
Mitigation of gestational diabetes-induced endothelial dysfunction through FGF21-NRF2 pathway activation involving L-Cystine
Congcong Sun, L. Wang, Huiya Huang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167329-167329
Closed Access
Congcong Sun, L. Wang, Huiya Huang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167329-167329
Closed Access
The p53/miRNA Axis in Breast Cancer
Reza Shah Hosseini, Seyed Mohammad Nouri, Pooja Bansal, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 11, pp. 549-558
Closed Access
Reza Shah Hosseini, Seyed Mohammad Nouri, Pooja Bansal, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 11, pp. 549-558
Closed Access
Redox regulation of cancer stem cells: Biology and therapeutic implications
Min Du, Jian Zhang, Max S. Wicha, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access
Min Du, Jian Zhang, Max S. Wicha, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access
